Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Huangbai Liquid (Fufang Huangbai Ye) is a Traditional Chinese Medicine (TCM) topical solution widely used in China for wound healing and the treatment of inflammatory skin conditions. It is a complex formulation typically containing extracts from *Phellodendron amurense* (Huangbai), *Lonicera japonica* (Jinyinhua), *Forsythia suspensa* (Lianqiao), *Gardenia jasminoides* (Zhizi), and *Taraxacum mongolicum* (Pugongying). The preparation exhibits potent anti-inflammatory, antibacterial, and analgesic properties. It is clinically indicated for the treatment of suppurative wounds, diabetic foot ulcers, pressure sores, and postoperative infections. By inhibiting bacterial growth and modulating the local inflammatory environment, it promotes the formation of granulation tissue and accelerates the re-epithelialization process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound huangbai liquid.